EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Anti-SARS-CoV-2 antibodies following vaccination are associated with lymphocyte count and serum immunoglobulins in SLE

John A Reynolds iD, Sian E Faustini, Sofia Tosounidou, Tim Plant, Mandeep Ubhi iD, Rebecca Gilman, Alex G Richter, Caroline Gordon iD

Lupus · 2023

DOI: 10.1177/09612033231151603 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Lupus, 2023. Verfasst von John A Reynolds und 7 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, 1724University of Birmingham, Birmingham, …. Hauptthemen laut MEDLINE: COVID-19, Lupus Erythematosus, Systemic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sandwell and West Birmingham Hospitals NHS Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Patients with Systemic Lupus Erythematosus are known to have dysregulated immune responses and may have reduced response to vaccination against COVID-19 while being at risk of severe COVID-19 disease. The aim of this study was to identify whether vaccine responses were attenuated in SLE and to assess disease- and treatment-specific associations.

Methods

Patients with SLE were matched by age, sex and ethnic background to healthcare worker healthy controls (HC). Anti-SARS-CoV-2 spike glycoprotein antibodies were measured at 4–8 weeks following the second COVID-19 vaccine dose (either BNT162b2 or ChAdOx1 nCoV-19) using a CE-marked combined ELISA detecting IgG, IgA and IgM (IgGAM). Antibody levels were considered as a continuous variable and in tertiles and compared between SLE patients and HC and associations with medication, disease activity and serological parameters were determined.

Results

Antibody levels were lower in 43 SLE patients compared to 40 HC ( p < 0.001). There was no association between antibody levels and medication, lupus disease activity, vaccine type or prior COVID infection. Higher serum IgA, but not IgG or IgM, was associated with being in a higher anti-SARS-CoV-2 antibody level tertile (OR [95% CI] 1.820 [1.050, 3.156] p = 0.033). Similarly, higher lymphocyte count was also associated with being in a higher tertile of anti-SARS-CoV-2 (OR 3.330 [1.505, 7.366] p = 0.003)

Conclusion

Patients with SLE have lower antibody levels following 2 doses of COVID-19 vaccines compared to HC. In SLE lower lymphocyte counts and serum IgA levels are associated with lower antibody levels post vaccination, potentially identifying a subgroup of patients who may therefore be at increased risk of infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Lupus Erythematosus, SystemicHumansCOVID-19 VaccinesBNT162 VaccineChAdOx1 nCoV-19VaccinationLymphocyte CountAntibodies, ViralImmunoglobulin AImmunoglobulin M

Stichwörter der Autor:innen

COVID-19Systemic lupus erythematosusantibodiesvaccine response

Substanzen

COVID-19 VaccinesBNT162 VaccineChAdOx1 nCoV-19Antibodies, ViralImmunoglobulin AImmunoglobulin M

Autor:innen und Institutionen

  • Rheumatology Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, 1724University of Birmingham, Birmingham, UK.
  • Rheumatology Department, 1731Sandwell and West Birmingham NHS Trust, Birmingham UK.
  • Clinical Immunology Service, Institute for Immunology and Immunotherapy, 1724University of Birmingham, Birmingham, UK.

ORCID-Profile: John A Reynolds, Mandeep Ubhi, Caroline Gordon

Förderung

  • Sandwell and West Birmingham Hospitals NHS Trust

Zitieren

APA

Reynolds, J. A., Faustini, S. E., Tosounidou, S., Plant, T., Ubhi, M., Gilman, R., Richter, A. G., & Gordon, C. (2023). Anti-SARS-CoV-2 antibodies following vaccination are associated with lymphocyte count and serum immunoglobulins in SLE. Lupus. https://doi.org/10.1177/09612033231151603

Vancouver

Reynolds JA, Faustini SE, Tosounidou S, Plant T, Ubhi M, Gilman R, et al. Anti-SARS-CoV-2 antibodies following vaccination are associated with lymphocyte count and serum immunoglobulins in SLE. Lupus. 2023. doi:10.1177/09612033231151603

BibTeX
@article{Reynolds2023,
  author = {Reynolds, John A and Faustini, Sian E and Tosounidou, Sofia and Plant, Tim and Ubhi, Mandeep and Gilman, Rebecca and Richter, Alex G and Gordon, Caroline},
  title = {Anti-SARS-CoV-2 antibodies following vaccination are associated with lymphocyte count and serum immunoglobulins in SLE},
  journal = {Lupus},
  year = {2023},
  doi = {10.1177/09612033231151603}
}
Kostenlos starten →